Qtrex Quantum Ltd. QTEX

What this company does

We are a specialty medical device company the research, development, manufacturing, and commercialization of proprietary life support technologies. We aim for our technology to supersede and revolutionize the global mechanical ventilation market. The INSPIRA ART100 system utilizes a technique that circulated the patient’s blood, adding oxygen to the blood and removes carbon dioxide, with the enriched blood being circulated back to the patient, taking over the functionality of the heart and/or lungs in critical care patients undergoing life-saving procedures. The INSPIRA ART100 has received FDA 510(k) regulatory clearance for use in an extracorporeal perfusion circuit to pump blood during short-duration cardiopulmonary bypass procedures lasting 6 hours or less. Our goal is to support healthcare systems by providing a practical and portable solution facilitating the treatment of respiratory failure, without the need for mechanical ventilation, and with the ability to deploy INSPIRA ART systems in and outside of ICUs to an ambulatory treatment that can be administered in all hospital wards as well as in ambulances.

Written from the business description in QTREX Quantum Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 26 March 2026. Every sentence was checked against that document before publication.